Articles tagged with Immune System
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers have identified the specific gene implicated in Job's syndrome, a rare immunodeficiency disorder characterized by harmful bacterial and fungal infections. The discovery could benefit treatment for other immunodeficiency diseases and provide new leads for therapies.
Researchers at UCLA identified a distinct pattern of gene expression in immune cells from chronically lonely individuals. This finding suggests that social isolation affects the activity of genes driving inflammation and may provide a molecular framework for understanding its link to heart disease, viral infections, and cancer.
Immunology researchers at Thomas Jefferson University have successfully halted a lethal rabies infection in mice by opening the central nervous system's protective blood-brain barrier. This breakthrough could lead to improved treatment for late-stage rabies infections in humans, and may also shed light on other neurological diseases.
New clues from immune system molecules hold hope for overcoming antibiotic resistance, with shared structural and functional characteristics enabling these molecules to inhibit or kill microbial pathogens.
Research published in The Journal of Clinical Investigation shows that tumors use the enzyme IDO to directly activate existing regulatory T cells, which become strongly suppressive within a day. This discovery defines a tumor's survival strategy and suggests potential new leverage points for therapies.
VIB researchers have discovered that oral intake of allergens via the lactic acid bacterium Lactococcus lactis can treat various autoimmune and allergic disorders. This innovative strategy, patented by VIB, is being developed into biopharmaceutical medicines by ActoGeniX.
Scientists have identified a specific pathway, reactive-oxygen species (ROS), that allows cancer cells to evade the immune system. By targeting this pathway, researchers hope to develop new therapies that can break through the 'escape hatch' and accelerate or slow down T-cell activity.
HIV's uniformly fatal outcome and absence of natural immunity pose significant hurdles for vaccine design. The authors call for increased funding for research and clinical trials to address these challenges and accelerate progress in finding an effective AIDS vaccine.
A new $3.5 million program aims to train the immune system to detect and destroy cancerous tumors. Researchers will develop vaccines, enhance immune responses, and create imaging technologies to monitor the treatment's effectiveness.
A new vaccine has been developed to prevent hCMV infection and disease in mice, showing promise for human use. The vaccine generates an immune response that protects against both infection and disease by disarming the virus's ability to replicate.
Researchers compared genes involved in insects' immunity and their ability to spread disease, gaining insights into halting the transmission of diseases like malaria. By analyzing gene sequences with computers, scientists identified key genes to study, paving the way for new experimental research.
A team of scientists has identified over 350 immune system genes in the Aedes aegypti mosquito, which transmits deadly diseases like yellow fever and dengue. Understanding these genes' role in virus transmission could lead to new ways of combating these diseases by enhancing the mosquito's immune response.
Researchers at the University of Mainz have developed a novel approach to create antitumor vaccines by attaching tumor-associated glycopeptide antigens to a carrier protein via an immunocompatible thioether linkage. This method shows promise for inducing an immune response against cancer cells without irritating the immune system.
Researchers at UCLA's Jonsson Cancer Center have discovered a novel anti-inflammatory cell signaling pathway that may serve as a vital Yin-Yang mechanism to maintain the delicate balance of immune response. This discovery may lead to new ways to fight cancer and inflammatory diseases.
A study found that green tea compound epigallocatechin-3-gallate (EGCG) inhibits production of inflammatory molecules involved in joint damage. EGCG also blocks the production of interleukin-6 and prostaglandin E2, reducing inflammation in joints.
A microRNA in mouse immune cells is shown to balance the response of immune defenses, with its equivalent human gene playing a vital role. Knockout mice develop autoimmune symptoms and are less resistant to bacterial infections, highlighting the importance of this microRNA in the immune system.
New cancer vaccine studies are making progress in developing vaccines that can attack cancerous cells by stimulating the immune system. Researchers have found that a human papillomavirus vaccine continues to protect against HPV types 16 and 18, as well as other related viruses, with significant cross-protection.
A new pancreatic cancer vaccine has successfully stalled disease progression in a handful of patients three years post-vaccination, offering new insights into how the vaccine could be made more effective. The study found that the vaccine triggered an active immune response and slowed down cancer growth in four patients.
Researchers have discovered that bacteria can enter immune system cells through a pore in the cell membrane, triggering an immune response without activating Toll-like receptors. This finding offers new perspectives for developing human vaccines and drugs that target inflammatory responses in autoimmune diseases like rheumatoid arthritis.
Scientists have identified a key gene, LaeA, that governs the mold's ability to produce toxic compounds. The discovery opens new avenues for treating Aspergillus fumigatus infection, which has a 60-90% mortality rate in immunocompromised individuals.
Interferon gamma and interleukin-1 alpha molecules work together, collaborating like two halves of a key, to initiate various immune responses. This unexpected collaboration enhances the antiviral activity of interferon gamma, providing an extra layer of security for the body.
A key protein called Mal alerts the immune system to respond against invading bacteria, and research has found two variants that determine how the immune system responds. The findings suggest possible new treatments for malaria and TB, as well as insights into autoimmune diseases.
Researchers compared the immune responses of animals infected with 1918 and H5N1 influenza viruses, finding similar yet distinct reactions. The study aims to better understand how these viruses cause disease and develop new treatments.
Health Canada has approved COLD-fX as a preventative measure to boost the immune system, reducing frequency and severity of cold and flu symptoms. The product's safety profile is confirmed, with no known side effects or drug interactions for healthy individuals.
Researchers at Oncolytics Biotech have developed a harmless virus that not only kills tumor cells but also primes the immune system to mount a powerful defense against cancer. Studies have shown that reovirus exposure can activate dendritic cells, which then educate natural killer cells and T cells to attack the tumor.
Researchers have discovered a protein, GAPDH, that allows group B streptococci to colonize and cause infection in newborns. The protein modulates the immune system, increasing the risk of invasive bacterial infection.
An international EU project led by the University of Bonn aims to shed light on why the immune system weakens with age, particularly in elderly people. The researchers will analyze up to 40,000 blood samples to develop new medicines that can largely inactivate viruses and enable the immune system to deal with residual viruses.
Researchers discovered a new protein, Carabin, that acts as an internal brake to limit the immune system's response, preventing excessive inflammation. This discovery may have potential applications in stopping unwanted immune reactions, such as organ rejection.
A study published in Nature Immunology reveals that lymph node cells instruct immune system cells to leave healthy tissue alone, protecting the small intestine from attack. This finding may lead to new forms of treatment for autoimmune diseases such as Type 1 diabetes and multiple sclerosis.
A team of University of Iowa researchers has made significant progress in understanding how the deadly Francisella tularensis bacterium evades the human immune system. The study found that the bacteria can inhibit the ability of white blood cells called neutrophils to kill it, allowing it to replicate and cause harm.
Researchers found that manipulating proteins in the immune system could lead to new treatments for asthma, which shares similarities with parasitic infections. The study's findings suggest that targeting specific cytokines, such as IL-4 and IL-13, may help prevent lung damage in asthmatic patients.
A new study found that the loss of PTEN function in glioma cells leads to high levels of B7-H1 expression, making it harder for T-cells to kill cancer cells. This discovery may have implications beyond brain tumors and could affect the effectiveness of emerging therapies.
Scientists have developed a model of the phagosome using systems biology approach, facilitating study of its function and interactions. The model may lead to better understanding of infectious disease processes and development of new strategies to fight pathogens.
Scientists at Johns Hopkins Medicine discover that sildenafil and other erectile dysfunction drugs can unmask cancer cells, allowing the immune system to recognize and attack them. The study found that these drugs reduce tumor size in mice with colon and breast tumors by increasing nitric oxide levels.
A study in mice with type 1 diabetes shows that an initial immune response to proinsulin triggers the attack on other proteins, leading to disease development. The findings suggest a potential therapeutic target for preventing this spreading response.
The Baylor Research Institute has received a $6.2 million grant to establish a Center for Lupus Research, which will focus on understanding the immune system's role in lupus. The center aims to identify how lupus alters cells of the immune system, leading to abnormal protein levels and disease activity.
New research suggests that beta-agonist medications used in asthma treatment can increase type 2 T cell accumulation, potentially worsening related diseases. The study's findings highlight the need for anti-inflammatory corticosteroids in moderate to severe asthma treatment.
Researchers developed a vaccine that stimulates colorectal cancer patients' immune systems to fight cancerous cells, with 70% of patients producing TNF-alpha and GM-CSF in response. The vaccine works by generating infection-fighting white blood cells called T cells, which destroy cancer cells.
Researchers at Baylor College of Medicine found that immune system cells recruited from the body can cause muscle dysfunction leading to certain forms of heart failure. Treatment with serum amyloid P prevented the production of these fibroblasts and resulting fibrosis.
Researchers found that specific HLA Class I/HIV viral fragment combinations are associated with a more powerful antiviral response. The study suggests that genetic factors play a significant role in determining how well an individual's immune system controls HIV during early infection.
A novel combination therapy has been developed to prevent three common viruses – cytomegalovirus, Epstein-Barr virus, and adenovirus – in transplant patients. The treatment, called Trivirus-specific cytotoxic T lymphocytes (CTLs), proved effective and safe in a phase 1 trial, reducing the risk of death from these infections.
The St. Jude technique enables blood stem cells from parents or unmatched adult siblings, reducing the need for harsh treatments and boosting the chance of cure. The modified transplantation method accelerates immune system recovery and reduces the risk of infections.
A new study by UW researchers suggests that the 1918 flu pandemic was deadly due to a severe immune system response, contradicting the conventional wisdom of secondary infections. The study found activated genes related to immune responses and programmed cell death, indicating an overzealous host immune system.
A study published in Nature found that the reconstructed 1918 influenza virus induces a potent immune system response in mice, yet fails to prevent severe lung disease and death. Researchers hope to understand the trajectory of this infection and develop targeted therapies for other viral infections.
Dr. Kevin J. Tracey's theory of the inflammatory reflex reveals a direct link between brain and immune system via the vagus nerve, providing a new approach to treating chronic inflammatory diseases. By manipulating brain activity, individuals may be able to 'think' their way to feeling better.
Researchers at UNC Health Care have found a way to treat pemphigus vulgaris without shutting off the immune system. They used a known compound to turn off signals that trigger skin damage, preventing blistering and other signs of the disease.
New research reveals that the immune system's 'thermostat' operates in harmony, with pro-inflammatory and anti-inflammatory compounds working together to regulate inflammation. Interleukin 10 production is triggered by Interferon-γ and an antigen-presenting cell, highlighting a dynamic and coordinated response.
A study by Harvard Medical School researchers reveals that the immune system protein paired-immunoglobulin like receptor-B (PirB) inhibits neuronal plasticity in adult mice, while a deficiency in PirB leads to enhanced plasticity throughout life. This discovery has important implications for future studies and repairs of the brain.
Researchers found HIV survives treatment by hiding in gut mucosa, suppressing immune function. Early antiretroviral treatment and anti-inflammatory medications may improve treatment outcomes. Restoration of gut immune function is crucial to ridding the body of the virus.
Researchers at Indiana University School of Medicine – Northwest propose that a family of proteins producing PGLYRP can be used to develop medications for HIV/AIDS patients. These proteins appear to be the front line in defending the body from infection, mounting a defense long before the body's main immune system responds.
The USC-Harvard team identified a protein switch that regulates the immune response, shedding light on the balance between tolerance and aggression in autoimmune diseases. The finding supports the combinatorial control theory of gene expression, with implications for understanding signal transduction and transcriptional networks.
The study found that B7-H4, an immune system blocker, is present in aggressive kidney cancers and vessels, allowing the cancer to grow and spread. This discovery may lead to better treatment options for patients with renal cell carcinoma, a deadly form of kidney cancer.
Researchers aim to understand how prolonged space trips affect human immune systems by studying fruit flies on a Space Shuttle mission. The flies will be exposed to bacteria, fungi, and reduced gravity to determine if their weakened immune systems make them more susceptible to infection.
Researchers found that marrow stem cells have receptors that detect bacteria and viruses, triggering a response to fight pathogens. This discovery could lead to new treatments for leukemias and autoimmune diseases like lupus and rheumatoid arthritis.
Researchers have identified a protein peptide that regulates the immune system and prevents autoimmune disease in Type 1 diabetes. The peptide, p277, stimulates regulatory T cells to produce anti-inflammatory substances, weakening the immune response.
A new vaccine called NicVax is being tested to prevent and treat nicotine addiction, with the goal of helping smokers quit. The vaccine works by stimulating the immune system to produce antibodies that recognize nicotine molecules, preventing them from entering the brain.
Natural killer cells rely on receptor tyrosine kinases, such as Tyro3, to acquire their reconnaissance tool kit, allowing them to distinguish friend from foe. The study reveals that environmental signals, transmitted through Gas6 and protein S, trigger the maturation of natural killer cells.
Researchers at the University of Minnesota found a tiny population of cells in the intestine that signal T-cells to fight infections. This discovery may help study and develop treatments for diseases such as ulcerative colitis and Crohn's disease.
Researchers identified 37 HIV-1 protein fragments that triggered an immune response in cytotoxic T lymphocytes. Healthy donors responded with large quantities of interferon gamma, while infected patients showed only a small proportion of cells mounting an adequate response.
Grade 11 student James McLeod won $5,000 for his study on how the HIV/AIDS virus attacks specific cells in the body's immune system. He found that a protein molecule called CD127 prevents the delivery of a survival signal to T-cells, leading to their rapid death and compromised immune function.